Moderna COVID-19 Vaccine Booster Dose

Activity Preview

Join us as we continue our complimentary 3-part review of COVID-19 vaccine boosters. The first eLearning continuing pharmacy education (CPE), Pfizer-BioNTech COVID-19 Vaccine Booster Dose: Indications, Vaccine Effectiveness, and Safety, provides a framework for the ongoing research in this ever-evolving landscape. Learn about the clinical data behind the recommendation for a booster dose in specific populations, review data on Pfizer-BioNTech’s COVID-19 booster, assess risk vs benefit profiles, as well as hit on key points applicable to all currently available COVID-19 vaccines. This second installment will focus primarily on the Moderna COVID-19 vaccine’s Emergency Use Authorization to now include booster doses in specific populations as of October 20, 2021. We will briefly discuss the EUA then jump right into both peer-reviewed literature and highlights from the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting held for Coronavirus Disease 2019 (COVID-19) Vaccines.

Learning Objectives

At the completion of this activity, the participant will be able to:

  • List the population groups for which Moderna’s COVID-19 vaccine booster dose is approved for as outlined by the FDA’s EUA released on October 20, 2021.
  • Discuss the clinical evidence for Moderna’s COVID-19 vaccine booster dose.
  • Compare and contrast the safety data between the second vaccine dose and a booster dose.

Activity type: Knowledge-based
Target Audience: Pharmacists 

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for .75 contact hour of CPE credit (0.07 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-385-H06-P.

To obtain credit for completing Moderna COVID-19 Vaccine Booster Dose: Vaccine Effectiveness and Safety  participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.    

Initial release date: October 28, 2021
Expiration date: November 1, 2023 - No credit can be claimed after this date

Development

Moderna COVID-19 Vaccine Booster Dose: Vaccine Effectiveness and Safety is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association

Disclosures

Dr. Kieu Nguyen and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Fee

This learning product is free to APhA members and non-members

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-21-385-H06-P 0.075 CEUs October 28, 2021 - November 01, 2023